Bristol-Myers Squibb - 10% downside potential
When I see a stock go from 2.6 times sales to 6.4 times sales while revenues have fallen from $21 billion to $16 billion, you can tell that investors are hoping for something big coming down the road.
For now, I'll look for a trip down to the lower end of the rising regression channel.
Risk - $64 or $65. Target $53-$54.
Tim 4:25PM EST Feb 27, 2015
For now, I'll look for a trip down to the lower end of the rising regression channel.
Risk - $64 or $65. Target $53-$54.
Tim 4:25PM EST Feb 27, 2015
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.